FDA Proposal Threatens Transparency on Cancer Drug Safety and Efficacy
FDA documents have been a trove of information for researchers, leading to new insights about the safety and efficacy of a drug. An FDA proposal could end that.
Breast Cancer
BREAST CANCER ADVISOR
FEATURED CONTENT
-
-
Sensitive ctDNA Test Predicts Residual Breast Cancer Following Neoadjuvant Therapy
If validated, a patient-specific ctDNA assay for residual disease after neoadjuvant therapy could bring an end to the surgery-for-all approach in breast cancer. -
Everyone’s Conflicted: How Open Payments Did Little to Discourage Conflicts of Interest in Oncology
Since its inception, the Open Payments act does not appear to have prompted physicians to accept fewer payments from industry overall. -
The Disappointing Reality of Crowdfunding Cancer Care
If crowdfunding doesn’t work, here’s how oncologists can help patients with financial toxicity. -
Some Targeted Therapies May Miss the Mark
Ten different drugs continued to kill cancer cells even when their target proteins were removed.
VIDEO SERIES
The Phase 3 PlanB Trial
Continue to Work?
Drug Resistance to CDK4/6 Inhibitors
Comparing Ribociclib and Palbociclib
Ribociclib, Abemaciclib, and Palbociclib
The Potential of CDK4/6 Inhibitors
How Cyclin D Plays A Role
2016 SABCS: Clinical Insights Telli
2016 SABCS: Clinical Insights Oregan
HER2-positive Metastatic and TNBC
Frontline Treatments
Treatment-related Neuropathy
ER-positive, HER2-negative
Emerging Medicines
Triple-negative Breast Cancer
Insights from the Lab and Clinic
Trastuzumab Resistance
Biologic Role of HER2
Strategies in Management
BREAST CANCER NEWS
Cancer Screening Rates Lower Among Women With Diabetes
Patient Simulation Project in Lung, Breast Cancers Points to Improvements in Quality of Care
Prediagnosis Exercise May Reduce CV Risk in Breast Cancer
CDK4/6 Inhibitor + AI Therapy is Effective in Both Older and Younger Women With Breast Cancer
IHC Assays for PD-L1 Lack Concordance in Metastatic TNBC
Want to read more?
Please login or register first to view this content.
Next post in Breast Cancer
